Robert W. Baird Has Lowered Expectations for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective cut by equities researchers at Robert W. Baird from $20.00 to $19.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s price target suggests a potential upside of 14.00% from the company’s previous close.

A number of other analysts also recently issued reports on DOC. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 price target on the stock. Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their price objective for the company from $21.00 to $17.00 in a report on Monday, December 15th. Wall Street Zen cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, March 28th. Citigroup cut their target price on shares of Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating for the company in a research report on Wednesday, April 1st. Finally, Evercore decreased their target price on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Six investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $19.19.

Healthpeak Properties Stock Up 0.9%

DOC traded up $0.15 during trading on Monday, hitting $16.67. 183,278 shares of the company’s stock traded hands, compared to its average volume of 9,200,803. Healthpeak Properties has a 12-month low of $15.71 and a 12-month high of $19.68. The company’s 50 day simple moving average is $17.07 and its two-hundred day simple moving average is $17.44. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The stock has a market capitalization of $11.59 billion, a price-to-earnings ratio of 166.90, a PEG ratio of 8.84 and a beta of 1.10.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. During the same period last year, the firm posted $0.46 earnings per share. Healthpeak Properties’s revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Institutional Trading of Healthpeak Properties

Several large investors have recently added to or reduced their stakes in the business. Mather Group LLC. purchased a new stake in Healthpeak Properties during the third quarter valued at approximately $25,000. City Holding Co. bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $26,000. WPG Advisers LLC grew its position in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after acquiring an additional 1,197 shares during the period. Advocate Investing Services LLC purchased a new stake in shares of Healthpeak Properties in the 4th quarter worth $26,000. Finally, Rexford Capital Inc. purchased a new stake in shares of Healthpeak Properties in the 2nd quarter worth $28,000. 93.57% of the stock is currently owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.